Global Opioid-induced Constipation Market Survey and Trend Research 2018

May 2018 | 93 pages | ID: G9D4FA571A7EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (AstraZeneca, Takeda Pharmaceutical, Valeant Pharmaceuticals International, Abbott, Boehringer Ingelheim, Boehringer Ingelheim, C.B. Fleet, Cosmo Pharmaceuticals, Daewoong, Daiichi Sankyo, GlaxoSmithKline, Ironwood Pharmaceuticals, Johnson & Johnson, Merck, Mundipharma, Nektar Therapeutics, Pfizer, Progenics Pharmaceuticals, Shionogi, SLA Pharma, Sucampo, Synergy Pharmaceuticals, Theravance etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Opioid-induced Constipation Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 OPIOID-INDUCED CONSTIPATION MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 AstraZeneca (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Takeda Pharmaceutical (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Valeant Pharmaceuticals International (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Abbott (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 C.B. Fleet (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Cosmo Pharmaceuticals (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Daewoong (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Daiichi Sankyo (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 GlaxoSmithKline (Company Overview, Sales Data etc.)
4.12 Ironwood Pharmaceuticals (Company Overview, Sales Data etc.)
4.13 Johnson & Johnson (Company Overview, Sales Data etc.)
4.14 Merck (Company Overview, Sales Data etc.)
4.15 Mundipharma (Company Overview, Sales Data etc.)
4.16 Nektar Therapeutics (Company Overview, Sales Data etc.)
4.17 Pfizer (Company Overview, Sales Data etc.)
4.18 Progenics Pharmaceuticals (Company Overview, Sales Data etc.)
4.19 Shionogi (Company Overview, Sales Data etc.)
4.20 SLA Pharma (Company Overview, Sales Data etc.)
4.21 Sucampo (Company Overview, Sales Data etc.)
4.22 Synergy Pharmaceuticals (Company Overview, Sales Data etc.)
4.23 Theravance (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Opioid-induced Constipation Market 2012-2017, by Type, in USD Million
Table Global Opioid-induced Constipation Market 2012-2017, by Type, in Volume
Table Global Opioid-induced Constipation Market Forecast 2018-2023, by Type, in USD Million
Table Global Opioid-induced Constipation Market Forecast 2018-2023, by Type, in Volume
Table AstraZeneca Overview List
Table Opioid-induced Constipation Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Opioid-induced Constipation Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid-induced Constipation Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Opioid-induced Constipation Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Opioid-induced Constipation Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Opioid-induced Constipation Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Overview List
Table Opioid-induced Constipation Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Overview List
Table Opioid-induced Constipation Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Opioid-induced Constipation Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Opioid-induced Constipation Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ironwood Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Opioid-induced Constipation Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Opioid-induced Constipation Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma Overview List
Table Opioid-induced Constipation Business Operation of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid-induced Constipation Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid-induced Constipation Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Progenics Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi Overview List
Table Opioid-induced Constipation Business Operation of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SLA Pharma Overview List
Table Opioid-induced Constipation Business Operation of SLA Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sucampo Overview List
Table Opioid-induced Constipation Business Operation of Sucampo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synergy Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Theravance Overview List
Table Opioid-induced Constipation Business Operation of Theravance (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Opioid-induced Constipation Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Revenue Share, by Companies, in USD Million
Table Global Opioid-induced Constipation Sales Volume 2012-2017, by Companies, in Volume
Table Global Opioid-induced Constipation Sales Revenue Share, by Companies in 2017, in Volume
Table Opioid-induced Constipation Demand 2012-2017, by Application, in USD Million
Table Opioid-induced Constipation Demand 2012-2017, by Application, in Volume
Table Opioid-induced Constipation Demand Forecast 2018-2023, by Application, in USD Million
Table Opioid-induced Constipation Demand Forecast 2018-2023, by Application, in Volume
Table Global Opioid-induced Constipation Market 2012-2017, by Region, in USD Million
Table Global Opioid-induced Constipation Market 2012-2017, by Region, in Volume
Table Opioid-induced Constipation Market Forecast 2018-2023, by Region, in USD Million
Table Opioid-induced Constipation Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Opioid-induced Constipation Industry Chain Structure
Figure Global Opioid-induced Constipation Market Growth 2012-2017, by Type, in USD Million
Figure Global Opioid-induced Constipation Market Growth 2012-2017, by Type, in Volume
Figure Global Opioid-induced Constipation Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Opioid-induced Constipation Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region